Ledger.Open graph →
SEC Form D · filed March 4, 2019

PLx Pharma Inc

Offering
$15.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
HOUSTON, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

John W. Hadden Ii · HOUSTON, TXDirectorRobert J. Casale · Houston, TXDirectorGary J. Balkema · HOUSTON, TXDirectorEfthymios Deliargyris · HOUSTON, TXExecKirk J. Calhoun · HOUSTON, TXDirectorMichael J. Valentino · Denver, COExec · DirectorNatasha Giordano · Hoboken, NJExec · DirectorRita O'Connor · HOUSTON, TXExecRobert J. Casale · Houston, TXDirectorJohn W. Hadden Ii · HOUSTON, TXDirectorGary J. Balkema · HOUSTON, TXDirectorEfthymios Deliargyris · HOUSTON, TXExecKirk J. Calhoun · HOUSTON, TXDirectorMichael J. Valentino · DUBLIN, CAExec · DirectorNatasha Giordano · HOUSTON, TXExec · DirectorRita O'Connor · HOUSTON, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗